confirm the structure of dione 6a as in the case of hydrazone 4b. As expected, the DEPT spectrum with
complete multiplicity editing shows signals for one methylene group, two methyl groups, and eight
nonequivalent aromatic CH fragments (two of which have double intensity).
Thus, the reaction of 6-ethyl-8-formyl-7-hydroxy-3-(4-phenyl-4H-1,2,4-triazol-3-yl)chromone (1) with
2-azolylacetonitriles under mild conditions gives previously unreported 8-iminopyrano[2,3-f]chromen-4-ones,
whose acid hydrolysis leads to pyrano[2,3-f]chromene-4,8-diones containing azaheterocyclic substituents at C-3
and C-9.
TABLE 2. 1H NMR Spectra of Products 1, 4-6
Com-
pound
Chemical shifts, δ, ppm (SSCS, J, Hz)*
1
1.21 (3H, t, J = 7.6, 6-CH3CH2); 2.67 (2H, q, J = 7.6, 6-CH3CH2); 7.42 (5Н, s, C6H5);
7.91 (1H, s, H-5); 8.74 (1H, s, H-2); 8.81 (1H, s, H-5' Tr);*2 10.54 (1H, s, CHO);
12.82 (1H, s, OH)
4a
1.40 (3H, t, J = 7.2, 6-CH3CH2); 2.93 (2H, q, J = 7.2, 6-CH3CH2); 7.62 (5Н, s, NНС6H5);
7.69 (2H, d, J = 7.6, H-2'',6'' Ph); 7.78 (2Н, t, J = 7.6, H-3'',5'' Ph);
7.86 (1Н, t, J = 7.6, H-4'' Ph); 8.22 (1H, s, H-5); 8.53 (1H, s, H-2); 9.32 (1H, s, 8-CH);
9.34 (1H, s, H-5' Tr)
4b
5a
1.39 (3H, t, J = 7.2, 6-CH3CH2); 2.94 (2H, q, J = 7.2, 6-CH3CH2);
7.70 (2H, d, J = 8.0, H-2'',6'' Ph); 7.77 (2Н, t, J = 8.0, H-3'',5'' Ph);
7.84 (1Н, t, J = 8.0, H-4'' Ph); 7.86 (1H, d, J = 9.2, H-6'''); 8.14 (1H, s, H-5);
8.53 (1H, s, H-2); 8.58 (1H, dd, J5''',6''' = 9.2, J5''',3''' = 2.0, H-5"'); 9.14 (1H, s, 8-CH);
9.27 (1H, d, J = 2.0, H-3'''); 9.29 (1H, s, H-5' Tr)
1.43 (3H, t, J = 7.6, 6-CH3CH2); 2.66 (3H, s, CH3-4′′′ Th);
3.13 (2H, q, J = 7.6, 6-CH3CH2); 7.55 (1H, s, H-5′′′ Th); 7.61 (2H, d, J = 7.6, H-2'',6'' Ph);
7.66 (2Н, t, J = 7.6, H-3'',5'' Ph); 7.73 (1Н, t, J = 7.6, H-4'' Ph); 8.53 (1H, s, H-5);
8.80 (1H, s, H-2); 9.21 (1H, s, H-5' Tr); 9.47 (1H, s, H-10)
5b
5c
1.58 (3H, t, J = 7.6, 6-CH3CH2); 3.27 (2H, q, J = 7.6, 6-CH3CH2);
7.75-7.87 (9H, m, C6H5, p-BrC6H4); 8.06 (1H, s, H-5′′ Th); 8.66 (1H, s, H-5);
8.98 (1H, s, H-2); 9.41 (1H, s, H-5' Tr); 9.60 (1H, s, H-10)
1.49 (3H, t, J = 7.6, 6-CH3CH2); 3.19 (2H, q, J = 7.6, 6-CH3CH2);
7.65-7.77 (5H, m, C6H5); 7.97-8.04 (2H, m, H-5''',6''' Bt); 8.23 (1Н, d, J = 8.0, H-7''' Bt);
8.29 (1Н, d, J = 8.0, H-4''' Bt); 8.58 (1H, s, H-5); 8.91 (1H, s, H-2);
9.37 (1H, s, H-5' Tr); 9.52 (1H, s, H-10)
5d
5e
6a
1.57 (3H, t, J = 7.6, 6-CH3CH2); 3.52 (2H, q, J = 7.6, 6-CH3CH2);
7.73-8.17 (10H, m, 2C6H5); 8.46 (1H, s, H-5); 8.88 (1H, s, H-2); 9.39 (1H, s, H-5' Tr);
9.66 (1H, s, H-10)
1.49 (3H, t, J = 7.6, 6-CH3CH2); 3.19 (2H, q, J = 7.6, 6-CH3CH2);
4.30 (3H, s, N–CH3); 7.62-7.77 (5H, m, C6H5); 7.92–7.99 (4H, m, H-4'',5'',6'',7'');
8.73 (1H, s, H-5); 8.76 (1H, s, H-2); 9.50 (1H, s, H-5' Tr); 9.54 (1H, s, H-10)
1.46 (3H, t, J = 7.6, 6-CH3CH2); 2.82 (3H, s, CH3-4′′′ Th);
3.12 (2H, q, J = 7.6, 6-CH3CH2); 7.67 (2H, d, J = 8.0, H-2'',6'' Ph);
7.71 (2Н, t, J = 8.0, H-3'',5'' Ph); 7.80 (1Н, t, J = 8.0, H-4'' Ph); 7.82 (1H, s, H-5′′′ Th);
8.52 (1H, s, H-5); 8.81 (1H, s, H-2); 9.47 (1H, s, H-5' Tr); 9.63 (1H, s, H-10)
6b
6c
1.48 (3H, t, J = 7.6, 6-CH3CH2); 3.21 (2H, q, J = 7.6, 6-CH3CH2);
7.66-7.84 (9H, m, C6H5, p-BrC6H4); 8.27 (1H, s, H-5′′ Th); 8.55 (1H, s, H-5);
8.82 (1H, s, H-2); 9.42 (1H, s, H-5' Tr); 9.86 (1H, s, H-10)
1.48 (3H, t, J = 7.6, 6-CH3CH2); 3.16 (2H, q, J = 7.6, 6-CH3CH2);
7.67 (2H, d, J = 7.6, H-2'',6'' Ph); 7.72 (2Н, t, J = 7.6, H-3'',5'' Ph);
7.80 (1Н, t, J = 7.6, H-4'' Ph); 7.96 (1H, t, J = 8.0, H-6''' Bt);
8.04 (1H, t, J = 8.0, H-5''' Bt); 8.32 (1Н, d, J = 8.0, H-7''' Bt);
8.37 (1Н, d, J = 8.0, H-4''' Bt); 8.58 (1H, s, H-5); 8.85 (1H, s, H-2);
9.46 (1H, s, H-5' Tr); 9.83 (1H, s, H-10)
6d
1.44 (3H, t, J = 7.6, 6-CH3CH2); 3.12 (2H, q, J = 7.6, 6-CH3CH2);
7.62-8.16 (10H, m, 2C6H5); 8.50 (1H, s, H-5); 8.77 (1H, s, H-2); 9.43 (1H, s, H-5' Tr);
9.74 (1H, s, H-10)
_______
* The spectra were taken in DMSO-d6 (chromone 1) and CF3CO2D (4-6).
*2 Bt – benzothiazole, Th = thiazole, Tr = triazole.
1093